Financhill
Back

Verve Therapeutics Stock Predictions

Sell
32

VERV
Verve Therapeutics

Last Price:
5.30
Seasonality Move:
70.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Verve Therapeutics Stock Forecast

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 27.6% based on the past 3 years of stock performance.
  • Verve Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Verve Therapeutics Stock Undervalued?
    The current Verve Therapeutics [VERV] share price is $5.29. The Score for VERV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Verve Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 27.6% based on the past 3 years of stock performance.

Verve Therapeutics Stock Rating

Sell
32
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics overpriced?

  • Verve Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Verve Therapeutics Stock Price History

Is VERV stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com

52-Week Data

52-Week High:
21.04
52-Week Low:
4.90

Prediction Charts

Market Cap:
444.18M
Price in USD:
5.29
Volume:
4.54M
Beta:
1.90

Technical Analysis

SMA50:
5.97
SMA100:
9.38
SMA200:
10.95
52-Wk Change:
-72.14%

Stock Predictions

  • Is Verve Therapeutics stock public?
    Yes, Verve Therapeutics is a publicly traded company.
  • What is the Verve Therapeutics stock quote today?
    The Verve Therapeutics stock price is 5.29 USD today.
  • How to buy Verve Therapeutics stock online?
    You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-3 5.29 5.25 5.59 5.17
Jun-4 5.20 5.29 5.47 5.14
Jun-5 5.35 5.34 5.35 5.15
Jun-6 5.32 5.28 5.37 5.20
Jun-7 5.20 5.21 5.30 5.10
Jun-10 5.07 5.36 5.37 4.96
Jun-11 5.26 5.33 5.43 5.13
Jun-12 5.58 5.59 5.79 5.50
Jun-13 5.59 5.61 5.75 5.50
Jun-14 5.55 5.42 5.76 5.36
Jun-17 5.36 5.27 5.39 5.11
Jun-18 5.21 5.10 5.26 5.04
Jun-20 5.05 5.14 5.16 4.93
Jun-21 5.17 5.29 5.39 5.04

Verve Therapeutics Earnings

Verve Therapeutics Earnings Report: Per Share Verve Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Verve Therapeutics Forecast Revenue Growth

Verve Therapeutics Stock Analysis: Historical quarterly revenues per share for Verve Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.

* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.